Global Transdermal & Transmucosal Drug Delivery System Market Research Report 2023

Publication ID:

PB502234586

Publication Date:

February 22, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Transdermal/transmucosal drug delivery is a well-established accepted route of administration for therapeutically beneficial medicines. Transdermal/transmucosal drug delivery continues to play an important role in the development of a variety of therapeutic areas in both brand and generic products.听
Highlights
The global Transdermal & Transmucosal Drug Delivery System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Transdermal & Transmucosal Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Transdermal & Transmucosal Drug Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Transdermal & Transmucosal Drug Delivery System include 3M, Antares Pharma, Aveva Drug Delivery Systems, Corium International, DURECT, Pantec Biosolutions, Tapemark, Tesa Labtec and Mylan, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transdermal & Transmucosal Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transdermal & Transmucosal Drug Delivery System.
The Transdermal & Transmucosal Drug Delivery System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transdermal & Transmucosal Drug Delivery System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transdermal & Transmucosal Drug Delivery System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma
Segment by Type
Transdermal Drug Delivery System
Transmucosal Drug Delivery System
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transdermal & Transmucosal Drug Delivery System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transdermal & Transmucosal Drug Delivery System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Transdermal & Transmucosal Drug Delivery System Market Overview
1.1 Product Overview and Scope of Transdermal & Transmucosal Drug Delivery System
1.2 Transdermal & Transmucosal Drug Delivery System Segment by Type
1.2.1 Global Transdermal & Transmucosal Drug Delivery System Market Value Comparison by Type (2023-2029)
1.2.2 Transdermal Drug Delivery System
1.2.3 Transmucosal Drug Delivery System
1.3 Transdermal & Transmucosal Drug Delivery System Segment by Application
1.3.1 Global Transdermal & Transmucosal Drug Delivery System Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Transdermal & Transmucosal Drug Delivery System Market Size Estimates and Forecasts
1.4.1 Global Transdermal & Transmucosal Drug Delivery System Revenue 2018-2029
1.4.2 Global Transdermal & Transmucosal Drug Delivery System Sales 2018-2029
1.4.3 Global Transdermal & Transmucosal Drug Delivery System Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Transdermal & Transmucosal Drug Delivery System Market Competition by Manufacturers
2.1 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Manufacturers (2018-2023)
2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Transdermal & Transmucosal Drug Delivery System Average Price by Manufacturers (2018-2023)
2.4 Global Transdermal & Transmucosal Drug Delivery System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transdermal & Transmucosal Drug Delivery System, Product Type & Application
2.7 Transdermal & Transmucosal Drug Delivery System Market Competitive Situation and Trends
2.7.1 Transdermal & Transmucosal Drug Delivery System Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transdermal & Transmucosal Drug Delivery System Players Market Share by Revenue
2.7.3 Global Transdermal & Transmucosal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transdermal & Transmucosal Drug Delivery System Retrospective Market Scenario by Region
3.1 Global Transdermal & Transmucosal Drug Delivery System Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Transdermal & Transmucosal Drug Delivery System Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2018-2029
3.2.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2018-2023
3.2.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Region: 2024-2029
3.3 Global Transdermal & Transmucosal Drug Delivery System Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2018-2029
3.3.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2018-2023
3.3.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Region: 2024-2029
3.4 North America Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.4.1 North America Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Transdermal & Transmucosal Drug Delivery System Sales by Country (2018-2029)
3.4.3 North America Transdermal & Transmucosal Drug Delivery System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.5.1 Europe Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Transdermal & Transmucosal Drug Delivery System Sales by Country (2018-2029)
3.5.3 Europe Transdermal & Transmucosal Drug Delivery System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.6.1 Asia Pacific Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Transdermal & Transmucosal Drug Delivery System Sales by Country (2018-2029)
3.6.3 Asia Pacific Transdermal & Transmucosal Drug Delivery System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.7.1 Latin America Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Transdermal & Transmucosal Drug Delivery System Sales by Country (2018-2029)
3.7.3 Latin America Transdermal & Transmucosal Drug Delivery System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Transdermal & Transmucosal Drug Delivery System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2018-2029)
4.1.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2018-2023)
4.1.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Type (2024-2029)
4.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Type (2018-2029)
4.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2018-2029)
4.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2018-2023)
4.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Type (2024-2029)
4.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Type (2018-2029)
4.3 Global Transdermal & Transmucosal Drug Delivery System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2018-2029)
5.1.1 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2018-2023)
5.1.2 Global Transdermal & Transmucosal Drug Delivery System Sales by Application (2024-2029)
5.1.3 Global Transdermal & Transmucosal Drug Delivery System Sales Market Share by Application (2018-2029)
5.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2018-2029)
5.2.1 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2018-2023)
5.2.2 Global Transdermal & Transmucosal Drug Delivery System Revenue by Application (2024-2029)
5.2.3 Global Transdermal & Transmucosal Drug Delivery System Revenue Market Share by Application (2018-2029)
5.3 Global Transdermal & Transmucosal Drug Delivery System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 3M
6.1.1 3M Corporation Information
6.1.2 3M Description and Business Overview
6.1.3 3M Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 3M Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.1.5 3M Recent Developments/Updates
6.2 Antares Pharma
6.2.1 Antares Pharma Corporation Information
6.2.2 Antares Pharma Description and Business Overview
6.2.3 Antares Pharma Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Antares Pharma Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.2.5 Antares Pharma Recent Developments/Updates
6.3 Aveva Drug Delivery Systems
6.3.1 Aveva Drug Delivery Systems Corporation Information
6.3.2 Aveva Drug Delivery Systems Description and Business Overview
6.3.3 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aveva Drug Delivery Systems Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.3.5 Aveva Drug Delivery Systems Recent Developments/Updates
6.4 Corium International
6.4.1 Corium International Corporation Information
6.4.2 Corium International Description and Business Overview
6.4.3 Corium International Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Corium International Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.4.5 Corium International Recent Developments/Updates
6.5 DURECT
6.5.1 DURECT Corporation Information
6.5.2 DURECT Description and Business Overview
6.5.3 DURECT Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 DURECT Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.5.5 DURECT Recent Developments/Updates
6.6 Pantec Biosolutions
6.6.1 Pantec Biosolutions Corporation Information
6.6.2 Pantec Biosolutions Description and Business Overview
6.6.3 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pantec Biosolutions Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.6.5 Pantec Biosolutions Recent Developments/Updates
6.7 Tapemark
6.6.1 Tapemark Corporation Information
6.6.2 Tapemark Description and Business Overview
6.6.3 Tapemark Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Tapemark Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.7.5 Tapemark Recent Developments/Updates
6.8 Tesa Labtec
6.8.1 Tesa Labtec Corporation Information
6.8.2 Tesa Labtec Description and Business Overview
6.8.3 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Tesa Labtec Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.8.5 Tesa Labtec Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Mylan Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Teva
6.10.1 Teva Corporation Information
6.10.2 Teva Description and Business Overview
6.10.3 Teva Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Teva Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.10.5 Teva Recent Developments/Updates
6.11 Zosano Pharma
6.11.1 Zosano Pharma Corporation Information
6.11.2 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Description and Business Overview
6.11.3 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Zosano Pharma Transdermal & Transmucosal Drug Delivery System Product Portfolio
6.11.5 Zosano Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal & Transmucosal Drug Delivery System Industry Chain Analysis
7.2 Transdermal & Transmucosal Drug Delivery System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal & Transmucosal Drug Delivery System Production Mode & Process
7.4 Transdermal & Transmucosal Drug Delivery System Sales and Marketing
7.4.1 Transdermal & Transmucosal Drug Delivery System Sales Channels
7.4.2 Transdermal & Transmucosal Drug Delivery System Distributors
7.5 Transdermal & Transmucosal Drug Delivery System Customers
8 Transdermal & Transmucosal Drug Delivery System Market Dynamics
8.1 Transdermal & Transmucosal Drug Delivery System Industry Trends
8.2 Transdermal & Transmucosal Drug Delivery System Market Drivers
8.3 Transdermal & Transmucosal Drug Delivery System Market Challenges
8.4 Transdermal & Transmucosal Drug Delivery System Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

3M
Antares Pharma
Aveva Drug Delivery Systems
Corium International
DURECT
Pantec Biosolutions
Tapemark
Tesa Labtec
Mylan
Teva
Zosano Pharma

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂